Hirudotherapy in complex treatment of chronic heart failure

QR Code

Hirudotherapy in complex treatment of chronic heart failure

In total, 70 patients with coronary heart disease (CHD) and Functional Class II-III(NYHA) chronic heart failure (CHF) were administered standard treatment combined with hirudotherapy. In more than 50% of the participants, dyspnoea and peripheral edema reduction, plus increased physical stress tolera...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. P. Kusnetsova, V. A. Lusov, N. A. Volov, N. A. Smirnova, L. S. Bogdanova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2008-04-01
Series:	Российский кардиологический журнал
Subjects:	chronic heart failure hirudotherapy physical stress tolerance platelet aggregation hemostasis system
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1537
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OXYCARDIN EFFECTS ON HEMOSTASIS AND BLOOD RHEOLOGY IN PATIENTS WITH STABLE ANGINA
by: Sun Zhun Khuan, et al.
Published: (2009-10-01)

Disorders of the aggregation function of platelets against the background of a deficiency of certain vitamins and microelements in children
by: O. B. Gordeeva, et al.
Published: (2023-10-01)

Platelet aggregation under the conditions of vortex flow in vitro in patients with chronic heart failure
by: O. A. Trubacheva, et al.
Published: (2022-07-01)

PRIMARY HEMOSTATIC SYSTEM CONDITION IN MUCOVISCIDOSIS IN CHILDREN
by: O. B. Gordeeva, et al.
Published: (2014-01-01)

Platelet aggregation function test for children in order to determine the normative values in different age groups
by: O. B. Gordeeva, et al.
Published: (2022-04-01)

Heart rate variability and hemostatic parameters in patients with coronary heart disease and chronic heart failure
by: M. Z. Buy, et al.
Published: (2013-10-01)

The role of platelets in inflammation and immunity
by: S. P. Sviridova, et al.
Published: (2018-09-01)

Research of cGMP- and cAMP-dependent intracellular signaling systems in the insulin-mediated regulation of platelets aggregation activity in patients with heart failure and metabolic disturbances
by: O. N. Ogurkova, et al.
Published: (2012-12-01)

Combination of magnesium and pyridoxine: effects on hemostasis in young men with primary mitral valve prolapse
by: S. A. Chepurnenko
Published: (2009-08-01)

Coagulation disorders in myocardial infarction with nonobstructive coronary arteries
by: A. S. Pisaryuk, et al.
Published: (2024-10-01)

Significance of detecting antiphospholipid antibodies and genetic mutations of hemostasis for in vitro fertilization
by: V. I. Linnikov
Published: (2019-09-01)

Comprehensive Approach to Developing Baseline Reference Ranges for Platelet Function
by: Olga B. Gordeeva, et al.
Published: (2023-05-01)

Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers
by: Yu. V. Larina, et al.
Published: (2008-12-01)

The Use of Medicinal Leeches in Plastic Surgery
by: Kosta Y. Mumcuoglu, et al.
Published: (2025-07-01)

Platelet activation and red blood cell changes in thrombotic and rheological disturbances among coronary heart disease patients
by: T. E. Shirokova, et al.
Published: (2007-10-01)

Valproate-induced thrombocytopenia
by: N. V. Izmozherova, et al.
Published: (2024-04-01)

Atomic force microscopy method in the study of platelets of patients with end-stage of chronic heart failure
by: L. V. Kukharenko, et al.
Published: (2019-06-01)

FUNCTIONAL ACTIVITY OF PLATELETS FOR THE PATIENTS WITH CHRONICAL GENERELIZED PERIODONTITIS AND CORRECTION OF THE HYPERAGREGATIONAL CHANGES IN THE COMPLEX TREATMENT BY THE GINKGO BILOBA EXTRACT
by: N.M. Pavelko, et al.
Published: (2024-03-01)

Aspirin effectiveness in patients with rheumatoid arthritis and coronary heart disease who receive non-steroidal anti-inflammatory drugs
by: T. V. Kropotina, et al.
Published: (2013-04-01)

Microcirculatory injuries of patients with chronic generalized periodontitis and their correction with EHF-therapy
by: V. F. Kiritchuk, et al.
Published: (2003-06-01)

SOME FEATURES OF MORPHOFUNCTIONAL STATUS OF PERPHERAL BLOOD PLATELETS IN DONORS AND RECIPIENTS OF RENAL ALLOGRAFT
by: I. A. Vasilenko, et al.
Published: (2009-06-01)

DIAGNOSTICS OF HEMOSTASIS DISORDERS IN INFANTS
by: A. L. Mishchenko, et al.
Published: (2016-06-01)

GENOTYPE -786CC OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE NOS3 AS A FACTOR OF ADVERSE CORONARY HEART DISEASE COURSE AND INCREASED ON-TREATMENT PLATELET AGGREGATION
by: E. F. Muslimova, et al.
Published: (2017-11-01)

Platelet functions in healthy persons with genetic polymorphisms gpia(с807т), gpiiia(т1565с), gpipa(с434т), p2ry12(н1/н2), selp(-g1087a) platelet receptions
by: N. N. Strambovskaya
Published: (2013-11-01)

Features of vascular-platelet and coagulation hemostasis in relation to parameters of macular blood fl ow in women with preeclampsia
by: O. V. Kolenko, et al.
Published: (2021-12-01)

The concept of hemostasis disorders in severe leptospirosis
by: D. L. Moisova, et al.
Published: (2021-10-01)

Assessment of vascular-platelet hemostasis in patients with hemorrhagic forms of erysipelas
by: R. I. Ratnikova, et al.
Published: (2014-09-01)

Anti-aggregant therapy in patients with coronary heart disease and gastric ulcer
by: A. B. Sumarokov, et al.
Published: (2010-10-01)

Vascular and platelet hemostasis and microcirculation in arterial hypertension patients
by: L. L. Kirichenko, et al.
Published: (2005-08-01)

Hyperhomocysteinemia, intravascular hemostasis disturbances, and clinical course of myocardial infarction
by: V. A. Lusov, et al.
Published: (2007-04-01)

Stress Induced Platelet Dysfunction in Rats with Folic Acid-Deficient Hyperhomocysteinemia
by: S. V. Alisievitch, et al.
Published: (2006-12-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Lipid-lowering and anti-aggregant Allicor activity in patients with moderate hypercholesterolemia
by: N. I. Gromnatsky, et al.
Published: (2007-10-01)

DIABETES MELLITUS AND CARDIOVASCULAR COMPLICATIONS: FOCUS ON HEMOSTASIS
by: G. G. Petrik, et al.
Published: (2014-03-01)

CD63 Immunological Activation Versus Hemostatic Function: Platelet Alterations After Polytrauma
by: Gregor Roemmermann, et al.
Published: (2025-07-01)

Violation of the vascular platelet hemostasis as a risk factor of primary open-angle glaucoma progression
by: N. I. Kurysheva, et al.
Published: (2015-10-01)

Thrombocyte aggregation activity in the conditions of intensive light deprivation
by: V. F. Kirichuk, et al.
Published: (2020-07-01)

THE EFFECTIVENESS OF PAPAYA LEAF EXTRACT (CARICA PAPAYA L.) AS AN ANTIAGGREGATION AGENT ON PLATELET COUNT AND PLATELET AGGREGATION: IN VITRO STUDY
by: Ganjar Noviar, et al.
Published: (2025-07-01)

Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure
by: A. S. Lishuta, et al.
Published: (2024-06-01)

Hemodynamics, functional state of endothelium and renal function, platelets depending on the body mass index in patients with chronic heart failure and preserved systolic function.
by: Yu. Kushnir
Published: (2014-03-01)